Accreditation/Credit Designation

Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by independent medical education grants from Agios Pharmaceuticals, Bioverativ, a Sanofi Company, and Celgene Corporation.

Community Practice Connections™: Differentiating Diagnosis and Treatment to Fit the Patient With Hemolytic Anemia: A Case-Based Approach

Release Date: January 31, 2019
Expiration Date: January 31, 2020
Media: Internet - based

Activity Overview

Identifying and appropriately treating hemolytic anemias require careful diagnosis and classification of the underlying causes of symptoms. Distinguishing between treatment-induced anemias, disease-related anemias, and anemias of genetic origin is essential before beginning treatment strategies. Treatment decisions often depend on critical steps in managing supportive care while treating the underlying causes of disease. When managing myelodysplastic syndromes, pyruvate kinase deficiency, beta-thalassemia, aplastic anemia, and other hematologic disorders, the treatment of anemia is an essential aspect of patient care.

This exciting Web-based activity will highlight recent clinical advances in novel diagnostic, therapeutic, and patient-counseling strategies to maximize treatment and management of your patients with hemolytic anemias. This includes efficacy considerations, as well as development of strategies to identify and mitigate predictable treatment-related adverse events in a timely fashion.

This activity features expert commentary and insights from renowned clinical educators who will contextualize data highlights and key findings through a combination of didactic and case-based learning. The program will give you the opportunity to reflect on best practices and your own clinical decisions to personalize care for your patients with hemolytic anemias.

Acknowledgement of Commercial Support

This activity is supported by independent medical education grants from Agios Pharmaceuticals, Bioverativ, a Sanofi Company, and Celgene Corporation.

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review audio files/content until you finish the presentation.
  • At the end of the activity, educational content/audio files will be available for your reference.
  • In order to receive a CME certificate, you must complete the activity.
  • Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” You may immediately download a CME certificate upon completion of these steps.

Target Audience

This educational program is directed toward hematologists, medical oncologists, and other healthcare professionals interested in the latest advances in the diagnosis and treatment of patients with hemolytic anemias. Fellows, researchers, nurses, nurse practitioners, physician assistants, and other healthcare professionals interested in the diagnosis, treatment, and management of patients with hemolytic anemias are also invited to attend.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  1. Explain the approach to the differential diagnosis of patients with hemolytic anemias
  2. Describe recent evidence concerning evolving treatment strategies to care for patients with hemolytic anemias
  3. Incorporate knowledge of potential side effects of treatment to the approach to management of specific hemolytic anemias
  4. Apply recent evidence to inform clinical decision-making to manage patients with hemolytic anemias

Faculty, Staff, and Planners' Disclosures


Janet Kwiatkowski
Janet Kwiatkowski, MD, MSCE
Director of the Thalassemia Center
Children's Hospital of Philadelphia
Professor of Pediatrics
Perelman School of Medicine, University of Pennsylvania
Philadelphia, PA

Disclosures: Grant/Research Support: Novartis, ApoPharma, Terumo BCT, bluebird bio studies; Consultant: Celgene, bluebird bio, Agios

Rachael F. Grace
Rachael F. Grace, MD, MMSc
Assistant Professor of Pediatrics, Harvard Medical School
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Boston, MA

Disclosures: Grant/Research Support: Agios Pharmaceuticals; Other: Scientific Advisor – Agios Pharmaceuticals

Rami Komrokji, MD
Senior Member and Professor of Oncologic Sciences
Section Head-Leukemia and MDS
Vice Chair-Malignant Hematology Department
Moffitt Cancer Center
Tampa, FL

Disclosures: Grant/Research Support: Celgene, Novartis, Incyte, Jazz, Pfizer; Speakers Buereau: Novartis, Jazz

The staff of PER® have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By